UNSPSC 51471802: Aminacrine or aminoacridine

This classification denotes a topical anti-infective agent with the molecular formula C13H10N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 78OY3Z0P7Z, chemically known as 9-acridinamine, monohydrochloride but generally known as aminacrine, which bears US NIH Compound Identifier 7019. Aminacrine most often comes in base and hydrochloride forms. European Medicines Agency schedules Aminoacridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05437MIG.

UNSPSC 51471802 Aminacrine or aminoacridine is a Commodity code for a specific pharmaceutical ingredient, but the recent state and local opportunities tagged under it bear no connection to that chemical compound. The Hillsborough County Board of County Commissioners posted an IFB on July 7, 2026 for janitorial and operational supplies for its Fire Rescue Department (due July 24, 2026, estimated contract value $765,679.84), and the Minnesota Department of Administration, administering the MMCAP cooperative purchasing vehicle, posted an RFP on January 20, 2026 for generic multi-source pharmaceuticals and over-the-counter products (due March 26, 2026). The janitorial supplies solicitation calls for new, unused consumables delivered within 10 days to 47 fire stations operating around the clock; the pharmaceutical RFP seeks manufacturers to supply identified products through three authorized wholesalers with FDA compliance and cGMP certification required. Neither opportunity involves aminacrine or aminoacridine specifically, and the code shows little relevant recent activity aligned with its stated scope.

Geographic activity centers on Florida and Minnesota under these two opportunities, with MMCAP's cooperative purchasing structure extending participation to Oregon and other states. The Hillsborough County work requires delivery to Tampa, Florida; the MMCAP pharmaceutical contract serves multiple state and local government facilities across the cooperative alliance. Issuing bodies are a county board of commissioners and a multistate cooperative purchasing entity administered through a state procurement office. The pharmaceutical RFP imposes manufacturer-level requirements including workers' compensation and $5,000,000 commercial general liability insurance, cGMP and DSCSA compliance, and pricing submission in CSV format with performance penalties ranging from $200 to $1,500 per violation. The janitorial IFB requires authorized-distributor status, backorder and chain-of-custody documentation, and free-on-board destination pricing with no minimum purchase guarantees.